Globavir Biosciences

Share on: 
Description: 

Globavir is using  drug repurposing for treating global infectious diseases. Their lead drug candidate, GBV-006 is a combination of two FDA approved drugs and has shown efficacy in both in vitro as well as in vivo disease models affecting both viral load and mortality.

Location(s): 
Los Altos CA
United States